Tymazoline
![]() | |
Systematic (IUPAC) name | |
---|---|
2-[(5-methyl-2-propan-2-ylphenoxy)methyl]-4,5-dihydro-1H-imidazole | |
Clinical data | |
Trade names | Thymazen |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Nasal |
Identifiers | |
CAS Number |
24243-97-8 ![]() |
ATC code | R01AA13 |
PubChem | CID 34154 |
DrugBank |
DB08803 ![]() |
ChemSpider |
31478 ![]() |
UNII |
U993RH5585 ![]() |
KEGG |
D07373 ![]() |
Chemical data | |
Formula | C14H20N2O |
Molar mass | 232.321 g/mol |
| |
| |
![]() ![]() |
Tymazoline (trade name Thymazen in Poland) is a nasal decongestant that can be used to treat rhinitis. It acts as an antihistaminic and sympathomimetic, reducing swelling, inflammation and mucosal secretions.[1][2]
References
|
This article is issued from Wikipedia - version of the Sunday, October 13, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.